Zibo Buchang Pharmaceutical

Zibo Buchang Pharmaceutical is a prominent subsidiary of Shandong Buchang Pharmaceuticals, a leader in the Chinese Traditional Chinese Medicine (TCM) market. The company focuses on the research, development, and large-scale manufacturing of pharmaceutical products targeting cardiovascular and cerebrovascular conditions. Its operations are centered in Zibo, Shandong, where it maintains advanced GMP-certified facilities for the production of oral solids and injections. Zibo Buchang's portfolio includes widely recognized treatments such as Naoxintong capsules, which are integrated into clinical practice for stroke and coronary heart disease management. As a key production hub for the Buchang group, the company plays a vital role in the supply chain for one of China's largest domestic pharma networks. The firm continues to modernize traditional formulations through standardized extraction and quality control technologies.